首页> 中文期刊>中国药理学与毒理学杂志 >Antitumor activityand mechanism of JD20,a newly synthetic analog of natural ent-kaurane diterpenoid

Antitumor activityand mechanism of JD20,a newly synthetic analog of natural ent-kaurane diterpenoid

     

摘要

OBJECTIVE To study the anti-tumor activity and molecular mechanism of natural diter-pene derivative JD20 in vitro. METHODS Screening the sensitive of gastric carcinoma cell lines to JD20 by cytotoxicity test for 24 h.Cell morphology was evaluated by using DAPI.After staining of can-cer cells with PI or annexin V-FITC/PI respectively,the cell cycle and apoptosis induced by JD20 were detectded by flow cytometry. The change in cell membrane potential was detected by JC-1 test kit. Western blot method was used to detect the apoptosis-related protein. RESULTS The novel natural kaurane diterpene derivative JD20 had a significant inhibitory effect on tumor cells and was particularly active on gastric cancer cell lines HGC-27 (IC50=4.72 ± 1.37 μmol·L- 1) and MGC-803 (IC50=7.36 ± 0.86 μmol·L-1).Further studies found that JD20 resulted in thecell cycle arrest in the G2/M phase,and induced a significant apoptosis in HGC-27. In addition, JD20 also caused the drop of mitochondrial membrane potential of HGC-27 within a short time (3 h). Furthermore, the Western blotting analysis showed that JD20 could induce the up-regulation of p53,Bax and Bim protein expression in gastric can-cer cells,and the releasing of cytochrome c from the mitochondria into the cytoplasm,as well as the ac-tivation of casepase-9/3.CONCLUSION The natural kaurane diterpene derivative JD20 can inhibit the proliferation of various human cancer cells by blocking the cell cycle and inducing apoptosis, and its mechanism of inducing apoptosis may be related to the mitochondria-mediated apoptosis pathway.

著录项

  • 来源
    《中国药理学与毒理学杂志》|2018年第4期|346|共1页
  • 作者单位

    Clinical Pharmacology Laboratory,Pharmacy Department,Fuwai Centeral China Cardiovascular Hospital,Zhengzhou 451464,China;

    Clinical Pharmacology Laboratory,Pharmacy Department, Zhengzhou University People′s Hospital,Zhengzhou,450003,China;

    Clinical Pharmacology Laboratory,Pharmacy Department,Fuwai Centeral China Cardiovascular Hospital,Zhengzhou 451464,China;

    Clinical Pharmacology Laboratory,Pharmacy Department,Fuwai Centeral China Cardiovascular Hospital,Zhengzhou 451464,China;

    Clinical Pharmacology Laboratory,Pharmacy Department,Fuwai Centeral China Cardiovascular Hospital,Zhengzhou 451464,China;

    Clinical Pharmacology Laboratory,Pharmacy Department,Fuwai Centeral China Cardiovascular Hospital,Zhengzhou 451464,China;

    Clinical Pharmacology Laboratory,Pharmacy Department, Zhengzhou University People′s Hospital,Zhengzhou,450003,China;

    Clinical Pharmacology Laboratory,Pharmacy Department,Fuwai Centeral China Cardiovascular Hospital,Zhengzhou 451464,China;

    Clinical Pharmacology Laboratory,Pharmacy Department, Zhengzhou University People′s Hospital,Zhengzhou,450003,China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2023-07-25 15:02:57

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号